Free Trial
ASX:API

Australian Pharmaceutical Industries (API) Stock Price, News & Analysis

Australian Pharmaceutical Industries logo

About Australian Pharmaceutical Industries Stock (ASX:API)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
453,647 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
2.29%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Australian Pharmaceutical Industries Limited engages in the wholesale distribution of pharmaceutical, medical, health, beauty, and lifestyle products to pharmacies primarily in Australia. It also retails health and beauty products to consumers through a network of Priceline and Priceline Pharmacy franchise stores, and company owned Priceline stores in Australia; sells beauty products through Clear Skincare network of clinics in Australia and New Zealand; and manufactures and distributes pharmaceutical and toiletry goods to New Zealand, Australian, and Asian markets, as well as provides cosmetic products and non-invasive aesthetic beauty services. The company was founded in 1910 and is based in Camberwell, Australia.

Receive API Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Australian Pharmaceutical Industries and its competitors with MarketBeat's FREE daily newsletter.

API Stock News Headlines

The DOJ Just Paved the Way for Account Seizures
Washington is running out of money…And guess where they'll look next? When governments go broke, they take from the people. It's happened before, and it's happening again. The Department of Justice just admitted that cash isn't legally YOUR property.
Elon Musk's xAI launched its own API
See More Headlines

API Stock Analysis - Frequently Asked Questions

Australian Pharmaceutical Industries Limited (ASX:API) released its earnings results on Wednesday, April, 17th. The company reported $0.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.05 by $0.00.

Based on aggregate information from My MarketBeat watchlists, some other companies that Australian Pharmaceutical Industries investors own include Capricorn Metals (CMM), Allied Gaming & Entertainment (AGAE), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO), Berkeley Energia (BKY) and Global X Cloud Computing ETF (CLOU).

Company Calendar

Last Earnings
4/17/2019
Today
6/02/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Medical Equipment Wholesale
Sub-Industry
Computer Software
Current Symbol
ASX:API
CIK
N/A
Fax
N/A
Employees
1,310
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
1.28
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$4.00 billion
Price / Cash Flow
8.26
Book Value
A$0.89 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (ASX:API) was last updated on 6/2/2025 by MarketBeat.com Staff
From Our Partners